
The data was published in the journal Oncotarget in 2017. PMID: 28465479
KCTD11 antibody, N-term
GTX47451
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetKCTD11
Overview
- SupplierGeneTex
- Product NameKCTD11 antibody, N-term
- Delivery Days Customer9
- Application Supplier NoteWB: 0.2-2.5 ug/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5-1 mg/ml
- ConjugateUnconjugated
- Gene ID147040
- Target nameKCTD11
- Target descriptionpotassium channel tetramerization domain containing 11
- Target synonymsC17orf36, KCASH1, REN, REN/KCTD11, BTB/POZ domain-containing protein KCTD11, RING-type E3 ubiquitin transferase subunit KCTD11, potassium channel tetramerization domain-containing protein 11, retinoic acid, EGF, NGF induced gene protein
- HostRabbit
- IsotypeIgG
- Protein IDQ693B1
- Protein NameBTB/POZ domain-containing protein KCTD11
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Tong R, Yang B, Xiao H, et al. KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling. Oncotarget. 2017,8(23):37717-37729. doi: 10.18632/oncotarget.17145Read this paper








